ArticleMarine drugs2019
Development and Characterization of Astaxanthin-Containing Whey Protein-Based Nanoparticles.
Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 54 citations in OpenAlex.
- Fabrication of silk fibroin peptide-astaxanthin nanocomposites by nanoprecipitation for enhanced stability and antioxidant activity.Frontiers in nutrition · 2026Article
- Neuroprotective Potential ofPharmaceuticals (Basel, Switzerland) · 2025Article
- Protective effects of astaxanthin solid lipid nanoparticle as a promising candidate against acute kidney injury in rats.Naunyn-Schmiedeberg's archives of pharmacology · 2025Article
- Mitigation of Dietary Microplastic Accumulation and Oxidative Stress Response in Rainbow Trout (Animals : an open access journal from MDPI · 2025Article
- Unveiling astaxanthin: biotechnological advances, delivery systems and versatile applications in nutraceuticals and cosmetics.Archives of microbiology · 2025Review
- Astaxanthin: Past, Present, and Future.Marine drugs · 2023Review
- Nanoencapsulation of Anthocyanins from Red Cabbage (Antioxidants (Basel, Switzerland) · 2023Article
- Production and therapeutic use of astaxanthin in the nanotechnology era.Pharmacological reports : PR · 2023Review
- Microalgae Xanthophylls: From Biosynthesis Pathway and Production Techniques to Encapsulation Development.Foods (Basel, Switzerland) · 2021Review
- Recent Advances on Nanoparticle Based Strategies for Improving Carotenoid Stability and Biological Activity.Antioxidants (Basel, Switzerland) · 2021Review
- Phagocytosis of Astaxanthin-Loaded Microparticles Modulates TGFMarine drugs · 2021Article
- Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.Nanomaterials (Basel, Switzerland) · 2021Article
- Microalgae Encapsulation Systems for Food, Pharmaceutical and Cosmetics Applications.Marine drugs · 2020Review
- Astaxanthin and other Nutrients fromMarine drugs · 2020Review
- Recent Advances in Astaxanthin Micro/Nanoencapsulation to Improve Its Stability and Functionality as a Food Ingredient.Marine drugs · 2020Review
- The Astaxanthin Aggregation Pattern Greatly Influences Its Antioxidant Activity: A Comparative Study in Caco-2 Cells.Antioxidants (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Astaxanthin (ASX) is a carotenoid of great interest due to its potential health benefits. However, its use in the food, feed, and pharmaceutical fields is limited due to low bioavailability, poor stability during thermochemical treatments, susceptibility to oxidation, and poor organoleptic characteristics. The aim of this work was to develop a method to stabilize astaxanthin extracted from the microalgae
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.